Strategies to Bypass Side Effects by Targeting Additional Receptors To overcome the side effects associated with targeting a single glucagon family receptor, researchers are exploring combination therapies and the possibility of simultaneously targeting other receptors within the glucagon family, such as GIP (Gastric Inhibitory Peptide) receptor to enhance insulin secretion while mitigating the GI side effects of GLP-1R activation alone and Glucagon receptor to reduce glucose production in the liver without exacerbating hyperglycemia
10.1016/j.amjmed.2008.09.041 19 BullockB
DSIP helps normalize the stress-response rhythm so it stops firing when it shouldn't
PLoS One 9 , e100627 (2014)
Your healthcare provider may increase your dose every month, depending on how you tolerate the medication and if additional blood sugar control is needed
However, in studies exploring TBI in polytrauma patients, serum glucose metabolites have yet to show any significant patterns corresponding to brain injury or the thawed plasma response [24, 36]
